Sophia G Kisling
Overview
Explore the profile of Sophia G Kisling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah A, Jahan R, Kisling S, Atri P, Natarajan G, Nallasamy P, et al.
Cancer Lett
. 2024 Jul;
598:217097.
PMID: 38964729
Gemcitabine is the first-line treatment option for patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC). However, the frequent adoption of resistance to gemcitabine by cancer cells poses a...
2.
Shah A, Chaudhary S, Lakshmanan I, Aithal A, Kisling S, Sorrell C, et al.
NPJ Precis Oncol
. 2023 Aug;
7(1):74.
PMID: 37567918
Aberrantly expressed onco-mucin 16 (MUC16) and its post-cleavage generated surface tethered carboxy-terminal (MUC16-Cter) domain are strongly associated with poor prognosis and lethality of pancreatic (PC) and non-small cell lung cancer...
3.
Kisling S, Atri P, Shah A, Cox J, Sharma S, Smith L, et al.
Clin Cancer Res
. 2023 Jul;
29(18):3759-3770.
PMID: 37432996
Purpose: Despite the significant association of molecular subtypes with poor prognosis in patients with pancreatic ductal adenocarcinoma (PDAC), few efforts have been made to identify the underlying pathway(s) responsible for...
4.
Kisling S, Natarajan G, Pothuraju R, Shah A, Batra S, Kaur S
Cancer Metastasis Rev
. 2021 Sep;
40(3):721-738.
PMID: 34591244
Pancreatic cancer (PC) is a highly lethal malignancy with a 5-year survival rate of 10%. The occurrence of metastasis, among other hallmarks, is the main contributor to its poor prognosis....
5.
Jahan R, Shah A, Kisling S, Macha M, Thayer S, Batra S, et al.
Biochim Biophys Acta Rev Cancer
. 2020 Apr;
1873(2):188362.
PMID: 32298747
Trefoil factors 1, 2, and 3 (TFFs) are a family of small secretory molecules involved in the protection and repair of the gastrointestinal tract (GI). TFFs maintain and restore epithelial...